Both in Biotechnology
Kymera Therapeutics vs Repligen
Over the past year KYMR returned +112.8% and RGEN returned +18.7%; their daily moves had a correlation of 0.12.
KYMR +112.8% RGEN +18.7%Growth of $1, one year, split-adjusted
| Metric | KYMR | RGEN |
|---|---|---|
| Price | $127.09 | $178.27 |
| Market cap | $10.85B | $11.32B |
| Today | −0.33% | +3.08% |
| 1 month | +15.7% | −5.9% |
| 6 months | +53.7% | +41.9% |
| Year to date | +63.3% | +8.8% |
| 1 year | +105.5% | +19.6% |
| Revenue growth (YoY) | −100.0% | +10.9% |
| Gross margin | — | 53.0% |
| Net margin | — | −18.4% |
| P/E (TTM) | — | — |
| Price / sales | 106.1× | 14.0× |
| Net cash | $969.2M | $307.4M |
| Dividend yield | — | — |
| Volatility (60d) | 38.9% | 47.3% |
| Short % of float | 13.7% | 12.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).